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ABSTRACT
Introduction: The patient-centered movement
advocates for greater attention to the outcomes
that matter most to patients and their families. In
neurodegenerative disease, determination of
patient and caregiver priorities has received scant
attention in part because dementia patients are
deemed unreliable reporters. However, people
with mild cognitive impairment (MCI) likely
retain capacity to report their preferences.
Methods: In two separate MCI cohorts, we
conducted preliminary analyses of patient and
caregiver priorities among seven patient and
five caregiver outcomes of the HABIT Healthy
Action to Benefit Independence & Thinking
program (Mayo Clinic, Rochester, MN, USA).
Results: Via interview and paper-and-pencil
reporting both patient and caregiver
respondents’ ranked patient and caregiver
quality of life and patient self-efficacy as
highest priorities, ranking them ahead of
patient and caregiver mood, patient functional
status, patient distressing behaviors and
caregiver burden. Patients and caregivers
tended to value the outcomes for their loved
ones higher than their own outcomes.
Conclusion: Caregivers appeared to be
reasonable, but not perfect, proxies for patient
reports. Additional research with larger cohorts
and a more comprehensive range of outcomes is
needed.
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INTRODUCTION
The patient-centered outcomes research
movement has been galvanized and promoted
by the Patient-Centered Outcomes Research
Institute. Patient-centered outcomes research
includes helping people and their caregivers
consider their full range of healthcare options
in terms of the risk and benefits. Patient
centeredness promotes patients and caregivers
making and communicating healthcare
decisions informed by their personal
characteristics, conditions, and preferences.
One set of key preferences involves specifying
outcomes that matter most to patients and
caregivers [1].
Bringing patient centeredness to care and
research in the area of central nervous system
diseases, including neurodegenerative diseases,
is complicated by concerns about patients’
capacity to state their preferences in a fully
informed fashion [2]. For this reason, some have
argued that using patient and
caregiver-reported outcomes, such as quality of
life (QoL) [3] measures, is ill-suited to research
in Alzheimer’s disease (AD) or related
conditions [4]. However, modern
nomenclature of neurodegenerative disease
diagnosis recognizes an initial phase of the
illness characterized by concerning, but mild
cognitive impairments (MCI) with retained
functional capacities. These retained
functional capacities enable an individual to
establish health care preferences and participate
in health care decision-making [5]. This phase
of illness is labeled MCI [6–8] or mild
neurocognitive disorder [9]. Patients with MCI
are at high risk to progress to dementia, most
often related to AD. But patients with MCI do
not yet have the impairments in medical
decision-making capacity seen in patients with
mild dementia due to AD [5]. This status affords
a special opportunity to consider outcome
preferences for patients and their caregivers,
including the opportunity to determine
whether patient and caregiver preferences are
generally consistent across the couple and
whether they change with clinical intervention.
In the present pair of preliminary studies,
our aim was to explore the most important
behavioral outcomes for caregivers and patients
with MCI.
METHODS
We used convenience cohorts assembled from
the HABIT Healthy Action to Benefit
Independence and Thinking program (Mayo
Clinic, Rochester, MN [10]). HABIT is a
multi-component behavioral intervention
program for persons with MCI and their
partners. In the HABIT program, the patients
are referred to as the participants. The caregivers
are referred as ‘partners’ because in many case
they are not yet providing much care.
Patient/participant and caregiver/partner labels
are used interchangeably herein. Data
collection for this program focuses on an array
of patient- and caregiver-reported outcome
measures (see Table 1). Patients and caregivers
complete the measures listed in Table 1 just
before, immediately after and at one-year
intervals following the HABIT program. They
are thus familiar with the constructs we were
asking them to prioritize, at least as measured
by these instruments. This gave them the
opportunity to associate the outcomes we were
asking them to rank (e.g., patient’s
memory-based daily function) to a specific
measure (The Everyday Cognition scale, [11])
that the patients or their caregivers had
previously completed.
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The first study was intended to pilot our
forced-choice ranking method, so we limited
the cohort to cognitively intact caregivers that
had previously completed the HABIT program
with their participants who had MCI. These
caregivers were completing the outcome
measures as part of on-going longitudinal
follow-up of program outcomes. The caregivers
prioritized the importance of the various
constructs the program evaluation measures
were intended to assess. This analysis had the
additional benefit of addressing the problem
that caregivers’ preferences are generally not
considered when addressing priorities for, and
impacts of, treatments for dementia [12]. In the
second study, we sought to obtain the
perspective of the patient him or herself,
examine the concordance between patient and
caregiver rankings, and to explore whether
there were shifts in reported priorities from
pre- to post-treatment. In the second study,
patients with MCI and their respective
caregivers (different from the first study) were
surveyed. In study two, the patients and the
caregivers were surveyed immediately before
and immediately after completion of the HABIT
program. In both studies data were stored and
statistics performed using Microsoft Excel for




Participants in the HABIT program are generally
referred from the Behavioral Neurology or
Neuropsychology practices at the Mayo Clinic
though couples whom learn of the program via
the internet can be self-referred. Patients are
required to have a medical diagnosis of MCI.
Patients generally met standard Mayo
diagnostic criteria for MCI [7, 8]. Prior to
initiating the program cognitive status is
verified by administration of Dementia Rating
Scale (DRS) [13]. Patients must score [115 on
the DRS to participate in the program. All 36
caregiver alumni that completed the Mayo
HABIT program at Mayo Clinic Minnesota or
May Clinic Arizona during calendar year 2012
were candidates for the study. Three could not
be reached by phone. The remaining 33
contacted via telephone consented to
participate in in-person or telephone
interviews to follow-up on perceived
outcomes from the program. All caregivers had
previously completed the set of 12
patient/caregiver-centered outcomes measures
(See Table 1) routinely used to assess HABIT
clinical outcomes and evaluate the HABIT
program. Caregivers for the HABIT program
are required to have a Mini Mental State
Examination (MMSE) scores in the normal
range (C 27) and to have regular (at least once
weekly) contact with the person with MCI.
Interview
The primary author obtained consent and
completed a structured interview with all
caregivers. In the interview, she used the
method of pairwise comparisons for rank
ordering on a scale of 1 = most important to
12 = least important (see S1). It typically
required more than 30 paired comparisons to
determine the rank order.
Study 2
Participants
Couples attending the summer 2014 HABIT
sessions at Mayo Clinic Rochester agreed to
participate in the study. Rank prioritization was
again on scale from 1 = most important to
12 = least important. However, for this study
data were collected via paper forms rather than
186 Neurol Ther (2016) 5:183–192
in-person interview (see S2). Inclusion and
Exclusion criteria were the same as study 1.
Again all patients were required to have a
caregiver with at least once weekly contact
with the patient and MMSE C 27.
Pre and post-intervention rankings
Rankings were made no more than 1 month
prior to beginning of the 10-day program.
Participants and partners then completed the
five components of the program totaling 50 h of
intervention: (1) Memory compensation
training, (2) Yoga, (3) Computerized cognitive
stimulation, (4) Wellness education, (5) Support
group therapy. Patients and caregivers
completed the rank ordering of the 12
outcomes again on the last day of the program.
Compliance with Ethics
These studies were approved by the Mayo Clinic
Institutional Review Board. All procedures
followed were in accordance with the ethical
standards of the responsible committee on
human experimentation (institutional and
national) and with the Helsinki Declaration of
1964, as revised in 2013. Informed consent was




Partner respondents were 91% female with a
mean age of 71 years and 54% were college
graduates. In this analysis, 87% of caregivers
were spouses and the remainder were adult
children of the person with MCI. The results of
the rank ordering of outcome priorities of
caregivers of MCI patients are depicted in
Fig. 1. The patient’s QoL has the highest
average ranking and was endorsed as the most
important treatment outcome by 30% of
caregivers. Patients’ self-efficacy in handling
their MCI ranked second but was comparable
to patient QoL. Of note, caregivers did value
their own QoL but less than they valued the
patients’ QoL (p\.05). The patients’ daily
functioning on memory-based activities was
ranked in the upper half of outcomes but not
as highly as QoL outcomes. Caregiver
depression and burden were of least
importance among all treatment outcomes,
and ranked last by more than 25% of caregivers.
Study 2
All 16 couples attending the HABIT session
agreed to participate. Seventy-five percent of
the patient respondents were male. The mean
(standard deviation) age of patients was 77.3
(7.1) and mean education was 16.3 (2.5).
Caregivers were 81% female. Twelve of the
caregivers were spouses, and three more were
unmarried romantic partners. One caregiver
was a friend. Mean age of the caregiver group
was 73.1(7.5) and mean education was 14.9(1.5)
years. The pre- and post-intervention average
rankings for MCI patient and caregivers are
presented in Fig. 2.
Pre-program Rankings
On average patients ranked their own QoL and
self-efficacy first and second respectively,
followed by caregiver QoL and caregiver
mood. Distressing behaviors were least
concerning to the patients. Caregivers ranked
patient QoL, patient mood, and caregiver QoL
as the top three important outcomes,
respectively. Fifty percent of caregivers ranked
patient QoL as their top priority.
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Post-program Rankings
Dependent t tests showed a trend for patients to
have changed their prioritization of caregiver
burden after participation in the HABIT
program. This outcome moved from an
average ranking of 6.5 to an average of 4.3
(p = .09) suggesting increased concern about
their partner’s burden after participation in the
program As a result, on average, it moved from
sixth highest outcome to the highest ranking.
No other changes approached statistical
significance. None of the caregiver rankings
changed significantly from pre- to
post-intervention. There was one trend
observed. Patient depression trended toward
lower priority for caregivers, moving from the
second highest to the sixth highest average rank
(p = .06). This suggests that caregivers became
less concerned about patient’s mood outcomes
from baseline to end of program.
Patient Versus Caregiver Ranking
In comparing patient and caregiver pre-program
average rankings only one significant difference
emerged. Caregivers appeared more concerned
about patient depression than were the patients
(mean caregiver rank 4.2, mean patient rank
7.9, p\.01). Conversely there was a trend for
patients to be more concerned about caregiver
burden than are the caregivers themselves
(mean patient rank 6.2, mean caregiver rank
8.9, p = .08). However, patients and caregivers
agree the most important outcomes involve
QoL of patients, and that distressing behaviors
(hallucinations, delusions, agitation) are one of
























































































































Fig. 1 Mean rankings of post-intervention outcome
priorities for caregivers (study 1). Rank ordering on a
scale of 1 = most important to 12 = least important thus
lower rankings equal higher priority. Arcs identify rankings
that differ at p\ .05. Beh, behavior; Mem-Based Act,
memory-based activities of daily living; QoL, quality of life;
Prt, participant; Self-Eff, self-efﬁcacy
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DISCUSSION
We examined the relative importance of a
variety of patient-reported and
caregiver-reported outcomes to patients and
caregivers that were reporting on these
outcomes. The outcomes for patients included
basic and memory-based daily function,
anxiety, depression, distressing behaviors,
self-efficacy, and QoL. We also inquired about
caregiver outcomes including burden,
depression, anxiety, self-efficacy, and QoL. The
present results suggest that on average at the
MCI stage, patient QoL and self-efficacy are
most important to both patients with MCI and
caregivers. These priorities seemed to hold
across methods (face-to-face or phone
interview, paper-and-pencil survey). Concerns
about more traditional outcomes of anxiety,
depression, and daily function were not as
highly prioritized. These priorities may emerge
in later stages of neurodegenerative disease [14].
At the MCI stage, the caregivers and patients
seeking an intensive multi-component
behavioral intervention are focused on
patients’ opportunities to gain skills that may
sustain perceived QoL and enhance self-efficacy
regarding their ability to manage memory
impairment.
The results also show that on average the
high prioritization of QoL remains after an
intensive behavioral intervention. However,
the HABIT intervention completed by these
patients seemed to sensitize them to the needs
of their caregivers, causing their priority for
caregiver burden in particular, to rise to a top
concern post-treatment. Because we permitted
patients and caregivers to rate both patient and
Fig. 2 Pre- and post-intervention rankings for patients
with MCI and their caregivers (study 2). Rank ordering on
a scale of 1 = most important to 12 = least important
thus lower rankings equal higher priority. Asterisked line
identiﬁes rankings that differ at p\ .01. ADLS, activities
of daily living; QoL, quality of life; Prt, participant; Self-Eff,
self-efﬁcacy
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caregiver outcomes, we seemed to observe a ‘gift
of the Magi’ effect where patients and caregivers
prioritized their partners outcomes over their
own. Participation in the intervention program
seemed to amplify this effect. Permitting
patients and caregivers to prioritize their
partners’ as well as their own outcomes may
have led to lower estimates of concordance in
this study relative to others (cf. [15]).
This analysis is limited in several respects.
First, it focuses only the limited set of outcomes
used in our intervention program. We chose to
do this because we believed the completion of
the outcome measures for the program made the
respondents far more familiar with the
constructs they were ranking. Had they only
been prioritizing the constructs based on their
labels (e.g., ‘memory-based daily functions’)
there might have been more challenges
understanding what the terms meant.
Nevertheless, we acknowledge that a variety of
traditional clinical trial outcomes including
actual cognitive function and a range of
biomarkers (brain volumes, amyloid levels, etc.)
were not subjected to ranking. Including these
traditional outcomes in future examinations of
patient and caregiver outcome preferences could
be a focus of future analysis.
Second, our method of rank ordering places
certain constraints on how these outcomes may
relate to each other. We chose this method in
deference to other approaches (e.g., likert
scaling) as it was very easy for participants to
understand. We acknowledge that rank
ordering meant different outcomes could not
have equal importance to one another. All
outcomes were forced to be either more or less
important than those of proximal ranking.
Patients and caregivers may actually perceive
some of these outcomes to be equally important
(or unimportant). This approach could have
served to magnify differences in the rankings.
Conversely, the rank ordering system limited
the degree to which proximal items could differ,
i.e., by only one rank unit. For example, a
person could not declare that his or her highest
ranked item was far more important than the
second ranked item, which was only slightly
more important than the third ranked item.
Thus, the rank ordering may have served to
diminish the differences in how these outcomes
are actually valued. In any event, future studies
using different methods for determining patient
and caregiver outcome preferences are needed
to determine the reliability of the present
findings.
A final limitation is the nature of the cohorts
used in these studies. They were small
convenience samples. A larger sample would
have provided more power to identify statistical
differences between outcomes, groups,
subgroups, or time points. Moreover, the
sample is clearly limited in ethnic and
educational diversity. It is comprised of people
motivated to participate in an intensive
multi-component behavioral intervention. This
selection factor alone likely biases how different
outcomes are viewed. However, from a PCOR
research perspective the preferences of this group
are exactly the preferences to identify. That is, it
is a key to understand the preference of those
motivated to engage actively in interventional
trials to address MCI. No attempt is made in the
present analyses to suggest this is a
representative sample of all persons with MCI
or their caregivers.
CONCLUSION
The present findings provide preliminary
support for the importance of QoL and
self-efficacy outcomes to patients with MCI
and their caregivers. In addition, the findings
190 Neurol Ther (2016) 5:183–192
provide preliminary evidence that these
preferences are fairly stable even after
behavioral intervention. If these findings are
supported by future research, they can provide
valuable information for the design and focus of
programs intended to meet the needs of patient
and caregivers impacted by MCI.
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